$RKLB

Klein Frank sold $100K of RKLB

Klein Frank (Chief Operations Officer) sold 700 shares of Rocket Lab Corp (RKLB) at $143.05 ($0.10M total) on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Klein Frank
Published Jun 1, 2026, 10:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The disclosure confirms the transaction details (700 shares, ~$143.05/share) and that it was executed under a pre-arranged 10b5-1 plan, which generally dampens interpretive value.

02

Market read

Traders may briefly check for insider-selling trends, but the 10b5-1 structure makes this more of a compliance datapoint than a catalyst.

03

What to watch

The sale size (~$100k) is small relative to typical large-cap market impact; without additional insider buys/sells or guidance changes, the trading signal is likely weak.

Relevance 6/10Novelty 6/10Timing: Filed today; sale executed 2026-05-28 (10b5-1 open-market sale).

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for Rocket Lab.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab COO Klein Frank sold 700 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by unusual volume or other fundamental news.

Evidence & confidence

The filing provides a specific sale price/date and confirms a 10b5-1 plan, which typically lowers interpretive value for near-term fundamentals.

Market effects

Minor read-through for space/launch peers is possible, but this is a single-company insider transaction with low fundamental linkage.

None material indicated.

None material indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with management’s risk management or tax planning, which some traders may treat as a mild negative signal.

Key entities

  • Rocket Lab Corp

    Subject of the Form 4 insider transaction disclosure.

  • Klein Frank

    Chief Operations Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBMed

Is RKLB Stock A Buy Or A High-Beta Trap?

Rocket Lab (RKLB) trades at $66, down 56% from its 52-week high, with a high P/S ratio. Q2 2026 revenue was $234M, up 62% YoY, mainly from Space Systems. Neutron rocket launch and Iridium acquisition are delayed. Backlog is $2.36B. Management expects slow growth from Iridium.

$RKLBHighAI 8/10

Rocket Lab Falls 6% as SpaceX Flags Iridium Deal to the FCC, Intuitive Machines Slides 5%

Rocket Lab (RKLB) fell 6% to $63.82 after SpaceX filed an FCC complaint against Iridium, which could impact Rocket Lab's $8B acquisition. The deal's variable exchange ratio ties Iridium payouts to Rocket Lab's share price, amplifying regulatory risks. Intuitive Machines (LUNR) and AST SpaceMobile (ASTS) also slid 5% and 6% respectively, following broader sector weakness.

$RKLBHighAI 9/10

Rocket Lab's HASTE Is Flying Hypersonic Missions for the Pentagon. Here's the Defense Business Hiding Inside a Space Stock.

Rocket Lab (RKLB), a smaller competitor to SpaceX (SPCX), has developed HASTE, a suborbital launch vehicle for hypersonic testing, primarily for the Department of Defense. HASTE offers lower-cost, frequent testing, generating higher revenue per flight than standard Electron launches. Rocket Lab has secured around $500 million in HASTE contracts, contributing significantly to its projected 2026 revenue. The company also operates in satellite manufacturing and plans to expand with the acquisition

$INTCHighAI 8/10

Why Are Nasdaq, Dow Futures Trading Mixed Premarket? INTC, SLS, SPCX, RKLB, ASTS, RIOT, FRMI Stocks Are In Focus

U.S. stock futures were mixed on Tuesday, with Nasdaq and Russell 2000 futures up 0.1%, Dow futures down 0.1%, and S&P 500 futures flat. Investors await July CPI data and geopolitical tensions impact sentiment. Key earnings reports include SMCI, CRWV, CAVA, LITE, and SLS. NVDA labeled AI data centers as investable assets, INTC upsized its share sale to $20B, and RIOT secured a $9.1B deal. RKLB shares fell despite a revenue beat, ASTS extended selloff, and SPCX faced lockup expiration pressures.

$RKLBMedAI 8/10

Rocket Lab Stock: Bull vs. Bear

Rocket Lab (RKLB +2.04%) reported record revenue of $234M in Q2 2026, up 62% YoY, with a backlog of $2.36B. The company secured U.S. Space Force contracts but delayed its Neutron rocket launch. Despite growth, it trades at 51x sales and reported a $49M net loss in Q2. Neutron's success is critical for future profitability.